{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:29:17Z","timestamp":1772119757508,"version":"3.50.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,12,28]],"date-time":"2022-12-28T00:00:00Z","timestamp":1672185600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,28]],"date-time":"2022-12-28T00:00:00Z","timestamp":1672185600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1007\/s11010-022-04636-5","type":"journal-article","created":{"date-parts":[[2022,12,28]],"date-time":"2022-12-28T00:02:46Z","timestamp":1672185766000},"page":"1867-1885","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["LINC01023 Promotes the Hepatoblastoma Tumorigenesis via miR-378a-5p\/WNT3 Axis"],"prefix":"10.1007","volume":"478","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8287-948X","authenticated-orcid":false,"given":"Ramesh","family":"Bhandari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imran Ibrahim","family":"Shaikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajeev","family":"Bhandari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadikchha","family":"Chapagain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,12,28]]},"reference":[{"key":"4636_CR1","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/0037-198x(83)90014-7","volume":"18","author":"WL Smith","year":"1983","unstructured":"Smith WL, Franken EA, Mitros FA (1983) Liver tumors in children. Semin Roentgenol 18:136\u2013148. https:\/\/doi.org\/10.1016\/0037-198x(83)90014-7","journal-title":"Semin Roentgenol"},{"key":"4636_CR2","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.suronc.2007.07.002","volume":"16","author":"RL Meyers","year":"2007","unstructured":"Meyers RL (2007) Tumors of the liver in children. Surg Oncol 16:195\u2013203. https:\/\/doi.org\/10.1016\/j.suronc.2007.07.002","journal-title":"Surg Oncol"},{"key":"4636_CR3","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3727\/105221616x693639","volume":"17","author":"D Bell","year":"2017","unstructured":"Bell D, Ranganathan S, Tao J, Monga SP (2017) Novel advances in understanding of molecular pathogenesis of hepatoblastoma: a Wnt\/\u03b2-catenin perspective. Gene Expr 17:141\u2013154. https:\/\/doi.org\/10.3727\/105221616x693639","journal-title":"Gene Expr"},{"key":"4636_CR4","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1053\/j.semdp.2016.12.015","volume":"34","author":"D Sharma","year":"2017","unstructured":"Sharma D, Subbarao G, Saxena R (2017) Hepatoblastoma. Semin Diagn Pathol 34:192\u2013200. https:\/\/doi.org\/10.1053\/j.semdp.2016.12.015","journal-title":"Semin Diagn Pathol"},{"key":"4636_CR5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/mop.0000000000000046","volume":"26","author":"P Czauderna","year":"2014","unstructured":"Czauderna P, Lopez-Terrada D, Hiyama E, H\u00e4berle B, Malogolowkin MH, Meyers RL (2014) Hepatoblastoma state of the art: pathology, genetics, risk stratification, and chemotherapy. Curr Opin Pediatr 26:19\u201328. https:\/\/doi.org\/10.1097\/mop.0000000000000046","journal-title":"Curr Opin Pediatr"},{"key":"4636_CR6","doi-asserted-by":"publisher","first-page":"e27103","DOI":"10.1002\/pbc.27103","volume":"65","author":"AD Trobaugh-Lotrario","year":"2018","unstructured":"Trobaugh-Lotrario AD, L\u00f3pez-Terrada D, Li P, Feusner JH (2018) Hepatoblastoma in patients with molecularly proven familial adenomatous polyposis: clinical characteristics and rationale for surveillance screening. Pediatr Blood Cancer 65:e27103. https:\/\/doi.org\/10.1002\/pbc.27103","journal-title":"Pediatr Blood Cancer"},{"issue":"Suppl 1","key":"4636_CR7","doi-asserted-by":"publisher","first-page":"S78","DOI":"10.14735\/amko2016s78","volume":"29","author":"A Puchmajerov\u00e1","year":"2016","unstructured":"Puchmajerov\u00e1 A, K\u0159epelov\u00e1 A, Indr\u00e1kov\u00e1 J, S\u00edtkov\u00e1 R, Bala\u0161\u010dak I, Kruseov\u00e1 J, \u0160vojgr K, Kodet R, Kyn\u010dl M, V\u00edcha A, Macek M Jr (2016) Hepatoblastoma, etiology, case reports. Klin Onkol 29(Suppl 1):S78-82. https:\/\/doi.org\/10.14735\/amko2016s78","journal-title":"Klin Onkol"},{"key":"4636_CR8","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1002\/ajmg.1320330119","volume":"33","author":"V Mamlok","year":"1989","unstructured":"Mamlok V, Nichols M, Lockhart L, Mamlok R (1989) Trisomy 18 and hepatoblastoma. Am J Med Genet 33:125\u2013126. https:\/\/doi.org\/10.1002\/ajmg.1320330119","journal-title":"Am J Med Genet"},{"key":"4636_CR9","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1634\/theoncologist.5-6-445","volume":"5","author":"CE Herzog","year":"2000","unstructured":"Herzog CE, Andrassy RJ, Eftekhari F (2000) Childhood cancers: hepatoblastoma. Oncologist 5:445\u2013453. https:\/\/doi.org\/10.1634\/theoncologist.5-6-445","journal-title":"Oncologist"},{"key":"4636_CR10","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1146\/annurev-pathol-020117-044010","volume":"13","author":"JO Russell","year":"2018","unstructured":"Russell JO, Monga SP (2018) Wnt\/\u03b2-catenin signaling in liver development, homeostasis, and pathobiology. Annu Rev Pathol 13:351\u2013378. https:\/\/doi.org\/10.1146\/annurev-pathol-020117-044010","journal-title":"Annu Rev Pathol"},{"key":"4636_CR11","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1038\/onc.2016.304","volume":"36","author":"T Zhan","year":"2017","unstructured":"Zhan T, Rindtorff N, Boutros M (2017) Wnt signaling in cancer. Oncogene 36:1461\u20131473. https:\/\/doi.org\/10.1038\/onc.2016.304","journal-title":"Oncogene"},{"key":"4636_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11101406","author":"N Mavila","year":"2019","unstructured":"Mavila N, Thundimadathil J (2019) The emerging roles of cancer stem cells and Wnt\/beta-catenin signaling in hepatoblastoma. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers11101406","journal-title":"Cancers (Basel)"},{"key":"4636_CR13","doi-asserted-by":"publisher","first-page":"110851","DOI":"10.1016\/j.biopha.2020.110851","volume":"132","author":"S He","year":"2020","unstructured":"He S, Tang S (2020) WNT\/\u03b2-catenin signaling in the development of liver cancers. Biomed Pharmacother 132:110851. https:\/\/doi.org\/10.1016\/j.biopha.2020.110851","journal-title":"Biomed Pharmacother"},{"key":"4636_CR14","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.jhep.2007.12.020","volume":"48","author":"M Kim","year":"2008","unstructured":"Kim M, Lee HC, Tsedensodnom O, Hartley R, Lim YS, Yu E, Merle P, Wands JR (2008) Functional interaction between Wnt3 and Frizzled-7 leads to activation of the Wnt\/beta-catenin signaling pathway in hepatocellular carcinoma cells. J Hepatol 48:780\u2013791. https:\/\/doi.org\/10.1016\/j.jhep.2007.12.020","journal-title":"J Hepatol"},{"key":"4636_CR15","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.lungcan.2011.10.007","volume":"76","author":"N Nakashima","year":"2012","unstructured":"Nakashima N, Liu D, Huang CL, Ueno M, Zhang X, Yokomise H (2012) Wnt3 gene expression promotes tumor progression in non-small cell lung cancer. Lung Cancer 76:228\u2013234. https:\/\/doi.org\/10.1016\/j.lungcan.2011.10.007","journal-title":"Lung Cancer"},{"key":"4636_CR16","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.1038\/oncsis.2012.31","volume":"1","author":"SB Nambotin","year":"2012","unstructured":"Nambotin SB, Tomimaru Y, Merle P, Wands JR, Kim M (2012) Functional consequences of WNT3\/Frizzled7-mediated signaling in non-transformed hepatic cells. Oncogenesis 1:e31. https:\/\/doi.org\/10.1038\/oncsis.2012.31","journal-title":"Oncogenesis"},{"key":"4636_CR17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrc3419","volume":"13","author":"JN Anastas","year":"2013","unstructured":"Anastas JN, Moon RT (2013) WNT signalling pathways as therapeutic targets in cancer. Nat Rev Cancer 13:11\u201326. https:\/\/doi.org\/10.1038\/nrc3419","journal-title":"Nat Rev Cancer"},{"key":"4636_CR18","doi-asserted-by":"publisher","DOI":"10.1042\/bsr20192466","author":"YL Sha","year":"2019","unstructured":"Sha YL, Liu S, Yan WW, Dong B (2019) Wnt\/\u03b2-catenin signaling as a useful therapeutic target in hepatoblastoma. Biosci Rep. https:\/\/doi.org\/10.1042\/bsr20192466"},{"key":"4636_CR19","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/nrm.2017.104","volume":"19","author":"JD Ransohoff","year":"2018","unstructured":"Ransohoff JD, Wei Y, Khavari PA (2018) The functions and unique features of long intergenic non-coding RNA. Nat Rev Mol Cell Biol 19:143\u2013157. https:\/\/doi.org\/10.1038\/nrm.2017.104","journal-title":"Nat Rev Mol Cell Biol"},{"key":"4636_CR20","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.cell.2013.06.020","volume":"154","author":"I Ulitsky","year":"2013","unstructured":"Ulitsky I, Bartel DP (2013) lincRNAs: genomics, evolution, and mechanisms. Cell 154:26\u201346. https:\/\/doi.org\/10.1016\/j.cell.2013.06.020","journal-title":"Cell"},{"key":"4636_CR21","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s10142-016-0524-x","volume":"17","author":"E Deniz","year":"2017","unstructured":"Deniz E, Erman B (2017) Long noncoding RNA (lincRNA), a new paradigm in gene expression control. Funct Integr Genomics 17:135\u2013143. https:\/\/doi.org\/10.1007\/s10142-016-0524-x","journal-title":"Funct Integr Genomics"},{"key":"4636_CR22","doi-asserted-by":"publisher","first-page":"18732","DOI":"10.3390\/ijms160818732","volume":"16","author":"SS Tang","year":"2015","unstructured":"Tang SS, Zheng BY, Xiong XD (2015) LincRNA-p21: implications in human diseases. Int J Mol Sci 16:18732\u201318740. https:\/\/doi.org\/10.3390\/ijms160818732","journal-title":"Int J Mol Sci"},{"key":"4636_CR23","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1002\/1878-0261.12606","volume":"14","author":"X Tian","year":"2020","unstructured":"Tian X, Wu Y, Yang Y, Wang J, Niu M, Gao S, Qin T, Bao D (2020) Long noncoding RNA LINC00662 promotes M2 macrophage polarization and hepatocellular carcinoma progression via activating Wnt\/\u03b2-catenin signaling. Mol Oncol 14:462\u2013483. https:\/\/doi.org\/10.1002\/1878-0261.12606","journal-title":"Mol Oncol"},{"key":"4636_CR24","doi-asserted-by":"publisher","first-page":"2961","DOI":"10.7150\/jca.31004","volume":"10","author":"M Yu","year":"2019","unstructured":"Yu M, Yu S, Gong W, Chen D, Guan J, Liu Y (2019) Knockdown of linc01023 restrains glioma proliferation, migration and invasion by regulating IGF-1R\/AKT pathway. J Cancer 10:2961\u20132968. https:\/\/doi.org\/10.7150\/jca.31004","journal-title":"J Cancer"},{"key":"4636_CR25","doi-asserted-by":"publisher","first-page":"5423","DOI":"10.1038\/s41467-021-25430-9","volume":"12","author":"G Nagae","year":"2021","unstructured":"Nagae G, Yamamoto S, Fujita M, Fujita T, Nonaka A, Umeda T, Fukuda S, Tatsuno K, Maejima K, Hayashi A, Kurihara S, Kojima M, Hishiki T, Watanabe K, Ida K, Yano M, Hiyama Y, Tanaka Y, Inoue T, Ueda H, Nakagawa H, Aburatani H, Hiyama E (2021) Genetic and epigenetic basis of hepatoblastoma diversity. Nat Commun 12:5423. https:\/\/doi.org\/10.1038\/s41467-021-25430-9","journal-title":"Nat Commun"},{"key":"4636_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ydbio.2006.08.028","volume":"302","author":"B Zhang","year":"2007","unstructured":"Zhang B, Pan X, Cobb GP, Anderson TA (2007) microRNAs as oncogenes and tumor suppressors. Dev Biol 302:1\u201312. https:\/\/doi.org\/10.1016\/j.ydbio.2006.08.028","journal-title":"Dev Biol"},{"key":"4636_CR27","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.canlet.2009.04.031","volume":"285","author":"K Ruan","year":"2009","unstructured":"Ruan K, Fang X, Ouyang G (2009) MicroRNAs: novel regulators in the hallmarks of human cancer. Cancer Lett 285:116\u2013126. https:\/\/doi.org\/10.1016\/j.canlet.2009.04.031","journal-title":"Cancer Lett"},{"key":"4636_CR28","first-page":"2207","volume":"11","author":"X Pan","year":"2019","unstructured":"Pan X, Zhao L, Quan J, Liu K, Lai Y, Li Z, Zhang Z, Xu J, Xu W, Guan X, Li H, Yang S, Gui Y, Chen Y, Lai Y (2019) MiR-378a-5p acts as a tumor suppressor in renal cell carcinoma and is associated with the good prognosis of patients. Am J Transl Res 11:2207\u20132218","journal-title":"Am J Transl Res"},{"key":"4636_CR29","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12957-021-02166-w","volume":"19","author":"K Li","year":"2021","unstructured":"Li K, Zhang J, Zhang M, Wu Y, Lu X, Zhu Y (2021) miR-378a-5p inhibits the proliferation of colorectal cancer cells by downregulating CDK1. World J Surg Oncol 19:54. https:\/\/doi.org\/10.1186\/s12957-021-02166-w","journal-title":"World J Surg Oncol"},{"key":"4636_CR30","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41389-020-0203-6","volume":"9","author":"MG Tupone","year":"2020","unstructured":"Tupone MG, D\u2019Aguanno S, Di Martile M, Valentini E, Desideri M, Trisciuoglio D, Donzelli S, Sacconi A, Buglioni S, Ercolani C, Biagioni A, Fibbi G, Fattore L, Mancini R, Ciliberto G, Blandino G, Del Bufalo D (2020) microRNA-378a-5p iS a novel positive regulator of melanoma progression. Oncogenesis 9:22. https:\/\/doi.org\/10.1038\/s41389-020-0203-6","journal-title":"Oncogenesis"},{"key":"4636_CR31","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1002\/jcb.29445","volume":"121","author":"S Zheng","year":"2020","unstructured":"Zheng S, Li M, Miao K, Xu H (2020) lncRNA GAS5-promoted apoptosis in triple-negative breast cancer by targeting miR-378a-5p\/SUFU signaling. J Cell Biochem 121:2225\u20132235. https:\/\/doi.org\/10.1002\/jcb.29445","journal-title":"J Cell Biochem"},{"key":"4636_CR32","doi-asserted-by":"publisher","first-page":"W429","DOI":"10.1093\/nar\/gkl333","volume":"34","author":"HY Huang","year":"2006","unstructured":"Huang HY, Chien CH, Jen KH, Huang HD (2006) RegRNA: an integrated web server for identifying regulatory RNA motifs and elements. Nucleic Acids Res 34:W429\u2013W434. https:\/\/doi.org\/10.1093\/nar\/gkl333","journal-title":"Nucleic Acids Res"},{"key":"4636_CR33","doi-asserted-by":"publisher","first-page":"D92","DOI":"10.1093\/nar\/gkt1248","volume":"42","author":"JH Li","year":"2014","unstructured":"Li JH, Liu S, Zhou H, Qu LH, Yang JH (2014) starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res 42:D92\u2013D97. https:\/\/doi.org\/10.1093\/nar\/gkt1248","journal-title":"Nucleic Acids Res"},{"key":"4636_CR34","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1101\/gr.082701.108","volume":"19","author":"RC Friedman","year":"2009","unstructured":"Friedman RC, Farh KK, Burge CB, Bartel DP (2009) Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 19:92\u2013105. https:\/\/doi.org\/10.1101\/gr.082701.108","journal-title":"Genome Res"},{"key":"4636_CR35","doi-asserted-by":"publisher","first-page":"W451","DOI":"10.1093\/nar\/gkl243","volume":"34","author":"J Kr\u00fcger","year":"2006","unstructured":"Kr\u00fcger J, Rehmsmeier M (2006) RNAhybrid: microRNA target prediction easy, fast and flexible. Nucleic Acids Res 34:W451\u2013W454. https:\/\/doi.org\/10.1093\/nar\/gkl243","journal-title":"Nucleic Acids Res"},{"key":"4636_CR36","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1093\/bioinformatics\/btt361","volume":"29","author":"K Liu","year":"2013","unstructured":"Liu K, Yan Z, Li Y, Sun Z (2013) Linc2GO: a human LincRNA function annotation resource based on ceRNA hypothesis. Bioinformatics 29:2221\u20132222. https:\/\/doi.org\/10.1093\/bioinformatics\/btt361","journal-title":"Bioinformatics"},{"key":"4636_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/ijms221910592","author":"PC Teng","year":"2021","unstructured":"Teng PC, Liang Y, Yarmishyn AA, Hsiao YJ, Lin TY, Lin TW, Teng YC, Yang YP, Wang ML, Chien CS, Luo YH, Chen YM, Hsu PK, Chiou SH, Chien Y (2021) RNA modifications and epigenetics in modulation of lung cancer and pulmonary diseases. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms221910592","journal-title":"Int J Mol Sci"},{"key":"4636_CR38","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1038\/mt.2016.180","volume":"24","author":"B Yue","year":"2016","unstructured":"Yue B, Cai D, Liu C, Fang C, Yan D (2016) Linc00152 functions as a competing endogenous RNA to confer oxaliplatin resistance and holds prognostic values in colon cancer. Mol Ther 24:2064\u20132077. https:\/\/doi.org\/10.1038\/mt.2016.180","journal-title":"Mol Ther"},{"key":"4636_CR39","doi-asserted-by":"publisher","first-page":"4151","DOI":"10.1038\/s41388-021-01839-w","volume":"40","author":"J You","year":"2021","unstructured":"You J, Li J, Ke C, Xiao Y, Lu C, Huang F, Mi Y, Xia R, Li Q (2021) Oncogenic long intervening noncoding RNA Linc00284 promotes c-Met expression by sponging miR-27a in colorectal cancer. Oncogene 40:4151\u20134166. https:\/\/doi.org\/10.1038\/s41388-021-01839-w","journal-title":"Oncogene"},{"key":"4636_CR40","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/jcmm.16036","volume":"25","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Lin W, Lin Y, Kang M, Zhu J, Tong Z, Wu L, Sun J, Lin J (2021) Long intergenic non-coding RNA Linc00485 promotes lung cancer progression by modulating miR-298\/c-Myc axis. J Cell Mol Med 25:309\u2013322. https:\/\/doi.org\/10.1111\/jcmm.16036","journal-title":"J Cell Mol Med"},{"key":"4636_CR41","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12349","author":"Y Yu","year":"2017","unstructured":"Yu Y, Yang J, Li Q, Xu B, Lian Y, Miao L (2017) LINC00152: a pivotal oncogenic long non-coding RNA in human cancers. Cell Prolif. https:\/\/doi.org\/10.1111\/cpr.12349","journal-title":"Cell Prolif"},{"key":"4636_CR42","doi-asserted-by":"publisher","first-page":"10993","DOI":"10.1038\/ncomms10993","volume":"7","author":"J Hyun","year":"2016","unstructured":"Hyun J, Wang S, Kim J, Rao KM, Park SY, Chung I, Ha CS, Kim SW, Yun YH, Jung Y (2016) MicroRNA-378 limits activation of hepatic stellate cells and liver fibrosis by suppressing Gli3 expression. Nat Commun 7:10993. https:\/\/doi.org\/10.1038\/ncomms10993","journal-title":"Nat Commun"},{"key":"4636_CR43","doi-asserted-by":"publisher","DOI":"10.26402\/jpp.2018.2.07","author":"B Taciak","year":"2018","unstructured":"Taciak B, Pruszynska I, Kiraga L, Bialasek M, Krol M (2018) Wnt signaling pathway in development and cancer. J Physiol Pharmacol. https:\/\/doi.org\/10.26402\/jpp.2018.2.07","journal-title":"J Physiol Pharmacol"},{"key":"4636_CR44","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.3389\/fphar.2019.01110","volume":"10","author":"X Nie","year":"2019","unstructured":"Nie X, Xia F, Liu Y, Zhou Y, Ye W, Hean P, Meng J, Liu H, Liu L, Wen J, Ren X, Chen WD, Wang YD (2019) Downregulation of Wnt3 suppresses colorectal cancer development through inhibiting cell proliferation and migration. Front Pharmacol 10:1110. https:\/\/doi.org\/10.3389\/fphar.2019.01110","journal-title":"Front Pharmacol"},{"key":"4636_CR45","doi-asserted-by":"publisher","first-page":"3849","DOI":"10.2147\/ott.S101782","volume":"9","author":"HS Wang","year":"2016","unstructured":"Wang HS, Nie X, Wu RB, Yuan HW, Ma YH, Liu XL, Zhang JY, Deng XL, Na Q, Jin HY, Bian YC, Gao YM, Wang YD, Chen WD (2016) Downregulation of human Wnt3 in gastric cancer suppresses cell proliferation and induces apoptosis. Onco Targets Ther 9:3849\u20133860. https:\/\/doi.org\/10.2147\/ott.S101782","journal-title":"Onco Targets Ther"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-022-04636-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-022-04636-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-022-04636-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T14:07:37Z","timestamp":1686751657000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-022-04636-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,28]]},"references-count":45,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["4636"],"URL":"https:\/\/doi.org\/10.1007\/s11010-022-04636-5","relation":{"references":[{"id-type":"uri","id":"","asserted-by":"subject"}],"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1283178\/v1","asserted-by":"object"}]},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,28]]},"assertion":[{"value":"21 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declared that no competing interest exists.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Institutional Ethical committee of Shanghai Tenth People hospital affiliated to Tongji University of medicine (Approval no:2016-STPH-1012863). All the Animals experiments were carried out following the approval by Animal protection and utilization committed of Tongji Hospital (No:TJ2016279778664034STH). We declare that all the patients were participated in this study were aware about the purpose and content of this research. A verbal and written consents were taken prior to their participant in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consents of publication"}}]}}